Scoot, Qatar, and Ryanair Top Cirium Global Airline Emissions Rankings in 2025
15.4.2026 12:00:00 EEST | Business Wire | Press release
Singapore-based Scoot has been named the world’s most emissions-efficient airline in Cirium’s 2025 EmeraldSky Annual Review, taking the top position from last year’s leader, Wizz Air. Qatar Airways, Ryanair, and Turkish Airlines were each recognized as the top three most efficient global airlines, ranked by available seat kilometres (ASK).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415951838/en/
EmeraldSky Gold 2025: Awarded to the world’s top five most emissions-efficient airlines, based on CO₂ per available seat kilometre (ASK).
Cirium’s industry leading ranking is based on CO₂ per available ASK across the world’s 100 largest airlines. The methodology is independently assured by PwC to ISAE 3000. It groups airlines into Gold, Silver and Bronze tiers based on global performance, which covers the top 15 airlines as well as key regional and route performers.
“Airline emissions performance comes down to decisions airlines can control — fleet choices, seat configuration and how aircraft are deployed on routes,” said Jeremy Bowen, CEO of Cirium. “The airlines at the top of these rankings have got those fundamentals right, and it shows. Better emissions efficiency and lower fuel bills go hand in hand.”
Scoot is the first Southeast Asian carrier to lead in global airline emissions efficiency rankings. Its average seat density of 242 seats per aircraft, operating on longer average sectors, placed it in the lead position this year. The results reinforce a consistent pattern across the industry. Airlines operating younger fleets with higher seat density continue to outperform their peers on emissions efficiency, with low-cost carriers dominating the top of the rankings. Wizz Air placed second (after placing first in 2024), followed by TUI Airways, Air Europa and Frontier Airlines, with all five carriers ranking in the top five globally and earning Gold status. Each has young fleets of aircraft compared to their peers.
Rank | Airline | Base Country | PAX CO2/ASK (g) | CO2 emissions (mt) | Flights per Year (thousands) | Fleet Age (years) | Avg. distance (km) |
1 | Scoot | Singapore | 51 | 2.0 | 65 | 6.7 | 2,157 |
2 | Wizz Air | Hungary | 52.9 | 6.2 | 335 | 4.7 | 1,547 |
3 | TUI Airways | UK | 53.6 | 2.2 | 66 | 9.7 | 2,862 |
4 | Air Europa | Spain | 53.9 | 2.1 | 69 | 10 | 2,023 |
5 | Frontier Airlines | USA | 54.1 | 3.5 | 208 | 4.8 | 1,470 |
6 | TUIfly | Germany | 54.4 | 1.6 | 58 | 10.6 | 2,475 |
7 | Virgin Atlantic | UK | 54.5 | 2.8 | 27 | 6.8 | 6,566 |
8 | AirAsia X | Malaysia | 54.8 | 1.6 | 20 | 14 | 4,177 |
9 | Pegasus | Turkey | 55.9 | 3.8 | 233 | 5 | 1,372 |
10 | Jetstar | Australia | 56 | 3.7 | 183 | 11.1 | 1,623 |
11 | Condor | Germany | 56.15 | 2.29 | 55 | 11.2 | 2,883 |
12 | Spirit Airlines | USA | 56.77 | 3.78 | 217 | 6.4 | 1,535 |
13 | Iberia | Spain | 57.03 | 4.47 | 100 | 11.5 | 2,831 |
14 | Volaris | Mexico | 57.33 | 3.10 | 180 | 7.5 | 1,532 |
15 | IndiGo | India | 57.36 | 9.84 | 796 | 4.2 | 1,082 |
*Gold: Ranks 1-5 | Silver: Ranks 6-10 | Bronze: Ranks 11-15. For the full list of 20 airlines, please reference the report. | |||||||
Wizz Air remains among the strongest performers with a fleet averaging under five years, similar to other performers such as Frontier Airlines and IndiGo.
Long-haul operators, in contrast, are closing the gap primarily through fleet renewal, by removing from service older, less-fuel-efficient aircraft. Airlines such as Virgin Atlantic demonstrate that newer widebody aircraft and higher-capacity configurations can deliver competitive emissions performance even on long-distance routes.
Top Airlines by ASK
The table below reflects the top three most efficient global airlines, ranked by available seat kilometres (ASK). The top 10 global airlines as ranked by ASK, are listed in the full report.
Rank | Airline | Base Country | PAX CO2/ASK (g) | CO2 emissions (mt) | Flights per Year (thousands) | Fleet Age (years) | Avg. distance (km) |
1 | Qatar Airways | Qatar | 60.0 | 15.4 | 198 | 10.2 | 4,221 |
2 | Ryanair | Ireland | 62.7 | 17.4 | 1148 | 10.1 | 1,264 |
3 | Turkish Airlines | Türkiye | 64.2 | 15.8 | 428 | 9.7 | 2,332 |
Regional and Key Intra Regional Rankings
The table below reflects regional rankings, as well as for well-trafficked corridors, the Transatlantic and Transpacific. Across every region, airlines with younger fleets and higher seat density continue to lead within their markets. Results in each region carry their own story as metrics of comparison change.
Rank | Airline | Base Country | PAX CO2/ASK (g) | CO2 Emissions (mt) | Flights (000s) | Fleet Age (yrs) | Avg. Dist. (km) |
Intra-North America | |||||||
1 | Frontier Airlines | USA | 54.5 | 3.0 | 185 | 4.8 | 1,402 |
2 | Spirit Airlines | USA | 57.4 | 3.1 | 185 | 6.5 | 1,463 |
3 | WestJet | Canada | 67.0 | 2.4 | 175 | 11.5 | 1,348 |
Europe | |||||||
1 | Wizz Air | Hungary | 53.1 | 3.9 | 222 | 4.6 | 1,462 |
2 | Jet2 | UK | 57.9 | 2.8 | 110 | 13.6 | 2,206 |
3 | Transavia | Netherlands | 59.9 | 2.0 | 116 | 10.5 | 1,491 |
Southeast Asia | |||||||
1 | VietJet Air | Vietnam | 64.5 | 1.4 | 107 | 8.2 | 941 |
2 | Singapore Airlines | Singapore | 66.7 | 0.90 | 45 | 5.9 | 1,181 |
3 | Lion Air | Indonesia | 67.1 | 1.1 | 90.0 | 13.3 | 828 |
Latin America | |||||||
1 | JetSmart | Chile | 57.9 | 1.1 | 92.0 | 3.1 | 1,033 |
2 | Volaris | Mexico | 58.8 | 2.0 | 137 | 7.6 | 1,297 |
3 | VivaAerobus | Mexico | 61.4 | 2.1 | 157 | 9.1 | 1,069 |
Transatlantic | |||||||
1 | Virgin Atlantic | UK | 53.7 | 1.8 | 16.9 | 6.5 | 6,759 |
2 | Air Canada | Canada | 54.9 | 2.7 | 24.4 | 14.4 | 6,108 |
3 | Aer Lingus | Ireland | 56.2 | 1.2 | 15.1 | 9.0 | 5,793 |
Transpacific | |||||||
1 | Air Canada | Canada | 56.2 | 1.6 | 8.9 | 10.2 | 10,178 |
2 | Delta Air Lines | USA | 57.5 | 1.9 | 11.3 | 6.1 | 9,945 |
3 | Cathay Pacific | China | 59.8 | 2.5 | 10.8 | 9.0 | 11,933 |
Airlines Closing the Gap: Capacity Growth Without Emissions Growth
Cirium’s 2025 review shows whether airlines are growing capacity faster than emissions. The table below ranks individual routes by the largest year-on-year reductions in CO2 per ASK and identifies the specific aircraft transition that drove each result. To qualify, a route must have operated at least 300 round trips in the year.
The metric highlights carriers making measurable progress, not just those already operating efficient fleets. Korean Air recorded the largest long-haul route improvements globally, driven by the transition to next-generation aircraft on key transpacific routes.
Rank | Route | Carrier | YoY CO₂/ASK Improvement | CO₂/ASK 2025 (g) | Fleet Transition | Avg. Seats | Route Dist. (km) |
1 | ICN – SEA | Korean Air | -27.4% | 53.6 | 777-300ERs → 787-9/10s | 308 | 8,376 |
2 | ICN – HNL | Korean Air | -22.4% | 52.3 | 747-8s & 777-300ERs → 787-10s | 327 | 7,354 |
3 | JFK – DEL | American Airlines | -20.4% | 59.8 | 777-300ERs → 787-9s | 285 | 11,756 |
4 | KEF – SEA | Icelandair | -20.3% | 57.9 | 757-200s → A321neos | 186 | 5,810 |
5 | JFK – GRU | American Airlines | -19.3% | 51.5 | 777-200ERs → 787-9s | 284 | 7,663 |
6 | LHR – HKG | British Airways | -18.1% | 64.3 | 777/787 family → A350-1000s | 303 | 9,631 |
7 | BOS – LHR | Delta Air Lines | -17.0% | 60.0 | A330-200s → A330-900neos | 268 | 5,241 |
8 | MSP – LHR | Delta Air Lines | -16.9% | 57.2 | A330-200s → A330-900neos | 281 | 6,443 |
9 | MUC – BOM | Lufthansa | -16.4% | 55.5 | A340-600s → A350-900neos | 293 | 6,312 |
10 | HKG – CDG | Cathay Pacific | -16.4% | 62.8 | 777-300ERs → A350-900neos | 287 | 9,590 |
"The route-level data tells a clear story," said Bowen. "When airlines swap older widebodies for next-generation aircraft, emissions per seat kilometre can fall by as much as 27 percent on that route within a year. This isn't theoretical — we're measuring it on real routes with real operational data."
About the EmeraldSky emissions report
Now in its second year, Cirium’s EmeraldSky Annual Review evaluates airline emissions intensity using CO₂ per available seat kilometre (ASK), based on analysis of the world’s 100 largest scheduled passenger airlines.
The 2025 edition also tracks year-on-year progress, measuring whether airlines are increasing capacity faster than emissions. The methodology uses flight-level operational data and is independently assured under ISAE 3000 by PwC. EmeraldSky is also accredited by the Rocky Mountain Institute as a qualified flight emissions data provider under the Pegasus Guidelines, the first climate-aligned finance framework for aviation.
About Cirium
Cirium is the world’s leading aviation analytics company. It delivers aviation analytics that power decision-making for airlines, airports, travel companies, aircraft manufacturers, and financial institutions. The company provides critical and timely information, analysis, and data including airline schedules, global aircraft and fleet developments, and operational, environmental, and financial performance for companies in the sector. Cirium is part of LexisNexis Risk Solutions, a RELX business that provides information-based analytics and decision tools for professional and business customers. RELX PLC shares trade on the London, Amsterdam, and New York Stock Exchanges (ticker symbols: London: REL; Amsterdam: REN; New York: RELX).
For more information, visit cirium.com or follow Cirium on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260415951838/en/
Contacts
For Cirium media inquiries please contact media@cirium.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom